Call Now

Recombinant Protein to Homo sapiens (Human) Cholinergic Receptor, Nicotinic, Alpha 4 (CHRNa4)

CHR-NA4; CHRN-A4; BFNC; EBN; EBN1; NACRA4; N-AChRA4; NAChRA4; N-AChR-A4; Neuronal Acetylcholine Receptor Alpha 4

DescriptionCholinergic Receptor, Nicotinic, Alpha 4 (CHRNa4)
Description Cholinergic Receptor, Nicotinic, Alpha 4 (CHRNa4)
Catalog NumberU928Hu01
Organism SpeciesHomo sapiens (Human)
SourceProkaryotic expression
Expression SystemE. coli
Endotoxin Level <1.0 EU per 1 µg (determined by the LAL method)
Subcellular LocalizationMembrane
Predicted Molecular Mass26.5kDa
Accurate Molecular Mass25kDa
Residues & TagsAsn49~Leu242 with N-terminal His Tag
Buffer Formulation 20 mM Tris, 150 mM NaCl, pH 8.0, 5% Trehalose and Proclin 300.
Form Supplied Lyophilized powder
Purity Purity was assessed by SDS-PAGE (≥98%) and by HPLC.
SDS-PAGE SDS-PAGE image for Cholinergic Receptor, Nicotinic, Alpha 4 (CHRNa4)
Isoelectric Point5.3
Applications Positive Control; Immunogen; SDS-PAGE; WB.
Storage Instruction We recommend a quick spin followed by reconstitution in water to a concentration of 0.1–1.0 mg/mL. This solution can then be diluted into other aqueous buffers and stored at 4°C for 1 week or at -20°C for future use.
Stability The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation testing at 37°C for 48 hours. No obvious degradation or precipitation was observed under the stated test conditions. The loss rate is less than 5% within the expiration date under appropriate storage conditions.
Notes For in vitro laboratory use only. Not for clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.